Day One Biopharmaceuticals, Inc.
DAWN
$6.80
$0.507.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.22% | -277.43% | 940.41% | 92.94% | -14.49% |
| Total Depreciation and Amortization | 17.79% | 1.74% | 82.84% | 251.72% | 12.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.86% | -87.40% | 167.99% | -944.49% | 22.92% |
| Change in Net Operating Assets | -221.59% | 151.21% | -202.90% | 4,075.88% | -68.03% |
| Cash from Operations | -96.60% | -159.13% | 203.31% | 1.21% | -20.20% |
| Capital Expenditure | 77.66% | -95.99% | -2,684.62% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.96% | -300.48% | -492.06% | -80.87% | 193.83% |
| Cash from Investing | 87.90% | -298.29% | -496.90% | -80.90% | 193.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -98.97% | 13,712.95% | 2,602.08% | -91.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -- | -99.07% | 15,327.53% | 2,602.08% | -91.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.24% | -262.60% | 695.12% | -177.70% | 481.02% |